STOCK TITAN
  1. Home
  2. News
  3. GDRX

GoodRx Holdings Inc - GDRX STOCK NEWS

Welcome to our dedicated news page for GoodRx Holdings (Ticker: GDRX), a resource for investors and traders seeking the latest updates and insights on GoodRx Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect GoodRx Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of GoodRx Holdings's position in the market.

News
GoodRx Announces Date for 2024 Investor Day
Rhea-AI Summary
GoodRx Holdings, Inc. (Nasdaq: GDRX) announced the date for its 2024 Investor Day on May 15, 2024, in New York City. The event will feature presentations by the Interim CEO, CFO, and other leaders, discussing business drivers, growth strategy, and a Q&A session. A live webcast link will be available on the investor relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.14%
Tags
none
-
News
GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call
Rhea-AI Summary
GoodRx Holdings, Inc. (Nasdaq: GDRX) announced the release of its first quarter 2024 financial results on May 9, 2024. The Company will hold a conference call and webcast to discuss the results and business outlook.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.3%
Tags
earnings
-
News
GoodRx Interim CEO Extends Commitment to Company
Rhea-AI Summary
GoodRx Holdings, Inc. announces board resignations with Interim CEO Scott Wagner extending commitment. Directors Stephen LeSieur and Adam Karol resign effective March 14 and March 22, 2024. Company expresses gratitude for their contributions and looks forward to continued growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.18%
Tags
none
News
GoodRx Reports Fourth Quarter and Full Year 2023 Results
Rhea-AI Summary
GoodRx Holdings, Inc. released its financial results for Q4 and full year 2023, showing revenue of $196.6 million in Q4 and $750.3 million for the year. The company reported a net loss of $25.9 million in Q4 and $8.9 million for the full year. Adjusted EBITDA was $57.3 million in Q4 and $217.4 million for the year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20.4%
Tags
earnings
-
News
GoodRx to Participate in Upcoming Investor Conferences
Rhea-AI Summary
GoodRx Holdings, Inc. (GDRX) executives will participate in investor conferences in March 2024, providing a live webcast and archived recordings for investors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.71%
Tags
conferences
-
News
GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
Rhea-AI Summary
GoodRx Holdings, Inc. (Nasdaq: GDRX) announced the release of its fourth-quarter and full-year 2023 financial results, along with plans for a conference call and webcast to discuss the results and the Company’s business outlook.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.14%
Tags
earnings
News
GoodRx Announces Proposed Refinancing of First Lien Credit Facilities
Rhea-AI Summary
GoodRx Holdings, Inc. (Nasdaq: GDRX) plans to refinance its first lien credit facilities, seeking to refinance its first lien term loan facility and amend its revolving credit facility to extend the maturity date. The terms of the proposed refinancing will be disclosed upon completion, expected during the Company’s first fiscal quarter of 2024. The proposed transaction is subject to the effectiveness of definitive documentation for the credit facilities and customary closing conditions, with no assurance of occurrence or specific terms.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.18%
Tags
none
-
News
The GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription Savings
Rhea-AI Summary
GoodRx (NASDAQ: GDRX) has saved Americans $65 billion and the healthcare system over $5 billion by improving medication access and adherence, positively impacting health outcomes and significantly reducing costs within the healthcare system. The company has saved consumers more than $65 billion on brand-name and generic prescription medications, with users saving an average of 82% on retail prices for prescription medications in the last year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.55%
Tags
none
-
News
GoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024
Rhea-AI Summary
GoodRx Holdings, Inc. (Nasdaq: GDRX) reported preliminary unaudited financial results for Q4 and full year 2023. Q4 Revenue expected to be $195-197 million, a 6-7% increase YoY. Full year 2023 Revenue expected to be $749-751 million, a 2% decrease YoY. Adjusted EBITDA Margins expected to be at the upper end of previous guidance range. The increase in revenue was primarily driven by organic growth in Prescription Transactions Revenue.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.31%
Tags
earnings
News
GoodRx Appoints Kelly J. Kennedy to Board of Directors
Rhea-AI Summary
GoodRx (Nasdaq: GDRX) appoints Kelly J. Kennedy, former CFO of The Honest Company, to its Board of Directors, bringing over 25 years of experience in retail and consumer brands. Kennedy will serve on the audit committee, leveraging her expertise in risk assessment management and financial reporting. She currently serves as CFO for Willow Innovations and has previously held CFO positions at The Bartell Drug Company and The Honest Company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.62%
Tags
management
Stock GDRX logo
GoodRx Holdings Inc

Nasdaq:GDRX

GDRX Rankings

#1599 Ranked by Market Cap
#2297 Ranked by Stock Gains
N/A Ranked by Dividends

GDRX Stock Data

2.70B
83.53M
11.89%
61.61%
2.34%
Data Processing, Hosting, and Related Services
Information
Link
US
Santa Monica

About GDRX

goodrx helps americans save on prescriptions. americans spend over $400 billion a year on prescriptions, and too many people simply can't find affordable prescriptions. even if you have insurance or medicare. we offer a website and mobile apps that gathers current prices, powerful savings tips and valuable discounts for every prescription drug at virtually every pharmacy in the us. goodrx is used by thousands of physicians and millions of americans each month. we have saved americans over $3 billion. we're not going to rest until prescriptions are affordable for all americans. we also offer goodrx for benefits, which provides technology solutions for health plans, payors and pbm's in an easy-to-understand website and mobile app experience. learn more at www.goodrx.com/benefits.